11.56%
science / life1 month ago

Bristol Myers' new cancer partnership is promising, but doesn't change our stance on the stock yet

https://www.cnbc.com/2025/06/02/bristol-myers-cancer-deal-is-promising-but-doesnt-change-our-stance-on-stock-yet.htmlhttps://finance.yahoo.com/news/bristol-pay-biontech-11-1-120708429.htmlhttps://www.stocktitan.net/news/BNTX/bio-n-tech-and-bristol-myers-squibb-announce-global-strategic-nu8ab0531qu5.html
Cnbc.com and 2 more
Bristol Myers' new cancer partnership is promising, but doesn't change our stance on the stock yet Open in Cnbc.com
Vote 2
0

References

Bristol to Pay BioNTech Up to $11.1 Billion in Cancer Deal

$11 Billion Deal: BioNTech and Bristol Myers Join Forces on Revolutionary Cancer Drug BNT327

$11 Billion Deal: BioNTech and Bristol Myers Join Forces on Revolutionary Cancer Drug BNT327

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Top 404 Internet News Today

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement